Clinical trial
Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)
NCT00316004 · University of Washington, Other · Terminated
Key facts
| NCT number | NCT00316004 |
|---|---|
| Title | Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI) |
| Official title | Phase 3 Study of Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI) |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Institute of Neurological Disorders and Stroke (NINDS) U.S. Army Medical Research and Development Command U.S. Fed Canadian Institutes of… |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain Injuries, Traumatic |
| Intervention type | Drug |
| Interventions | 7.5% Hypertonic Saline in 6% Dextran-70 (HSD), 7.5% Hypertonic Saline (HS), 0.9% Normal Saline (NS) |
| Enrollment | 1,331 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Apr 19, 2006 |
| Last update posted | May 19, 2011 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: